Actual Medicinal Product (AMP) - Rapamune 2mg tablets (Pfizer Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Rapamune 2mg tablets | Start Date 20-06-2003 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 08020200 | Start Date 24-06-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 4564711000001100 | 20-06-2003 |
Parent Products
-
VTMSirolimus
-
VMPSirolimus 2mg tablets
-
AMP(Current) Rapamune 2mg tablets (Pfizer Ltd) (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 30 tablet | 17298 | |
| 100 tablet | 60000 |